Inventor
SLAYMAKER IAN
US21 patents
⚠️ This page may combine multiple inventors who share the name “SLAYMAKER IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BROAD INST INC
16 patentsUS9790490B2Oct 17, 2017
CRISPR enzymes and systems
BROAD INST INC534 citations99
US11091798B2Aug 17, 2021
CRISPR enzymes and systems
BROAD INST INC32 citations97
US10648020B2May 12, 2020
CRISPR enzymes and systems
BROAD INST INC41 citations97
US11781172B2Oct 10, 2023
Crispr enzymes and systems
BROAD INST INC10 citations94
US10876100B2Dec 29, 2020
Crispr enzyme mutations reducing off-target effects
BROAD INST INC20 citations94
US10669540B2Jun 2, 2020
CRISPR enzymes and systems
BROAD INST INC31 citations94
US10494621B2Dec 3, 2019
Crispr enzyme mutations reducing off-target effects
BROAD INST INC35 citations94
US11773432B2Oct 3, 2023
CRISPR enzymes and systems
BROAD INST INC11 citations93
US11634755B2Apr 25, 2023
Crispr enzymes and systems
BROAD INST INC8 citations93
US12091709B2Sep 17, 2024
Crispr enzymes and systems
BROAD INST INC7 citations85
US12264359B2Apr 1, 2025
CRISPR enzymes and systems
BROAD INST INC1 citations74
US12410468B2Sep 9, 2025
CRISPR enzymes and systems
BROAD INST INC0 citations62
US12371737B2Jul 29, 2025
CRISPR enzymes and systems
BROAD INST INC0 citations62
US12123032B2Oct 22, 2024
CRISPR enzyme mutations reducing off-target effects
BROAD INST INC0 citations62
US11459557B2Oct 4, 2022
Use and production of CHD8+/− transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder
BROAD INST INC0 citations62
US12410416B2Sep 9, 2025
CRISPR enzymes and systems with modified pam specificity
BROAD INST INC0 citations51
BEAM THERAPEUTICS INC
5 patentsUS11142760B2Oct 12, 2021
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC14 citations93
US11344609B2May 31, 2022
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC6 citations84
US11155803B2Oct 26, 2021
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
BEAM THERAPEUTICS INC13 citations79
US11752202B2Sep 12, 2023
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC3 citations72
US12016908B2Jun 25, 2024
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC0 citations61